ClinicalTrials.Veeva

Menu

Efficacy of Autologous Adipose Derived Stromal Vascular Fraction for Musculoskeletal Conditions (SVF)

D

Dubai Health Authority

Status

Begins enrollment in 10 months

Conditions

Knee Osteoarthritis

Treatments

Procedure: stromal vascular fraction injection in the osteoarthritic knee

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

clinical efficacy of autologous stromal vascular fraction SVF,for inflammatory and degenerative conditions of the knees

Full description

to evaluate the clinical effectiveness of point of care autologous adipose derived stromal vascular fraction (SVF) alone or in combination with exosomes,for inflammatory and degenerative conditions of the knees.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • knee osteoarthritis any grade

    • knee chondromalacia grade 2 and above

Exclusion criteria

  • active HIV
  • pregnant women
  • Mental disease
  • severe cardio vascular disease
  • severe coagulation disorders
  • infected tissues
  • patients on other experimental studies within 3 months

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

300 participants in 1 patient group

knee osteoarhritis
Experimental group
Description:
patients with grade 2 and above chondromlacia as well as all grades of osteoarhtritis
Treatment:
Procedure: stromal vascular fraction injection in the osteoarthritic knee

Trial contacts and locations

0

Loading...

Central trial contact

mazen sawaf, MD; Amer Mansour, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems